The difference in BC-free survival between BRCA1-OC women (median: not reached; mean: 12.9 years) and BRCA2-OC women (median: not reached; mean: 15.9 years) did not reach statistical significance (p = 0.440). This evidence concerns the gene BRCA2 and breast cancer.